Countries Australia
Bayer Secures Key Resolution as Federal Court of Australia Ends Roundup™ Litigation
Federal Court of Australia discontinues the last pending case This follows significant win in first Roundup™ final judgment on non-Hodgkin l...
January 06, 2025 | News
Innovent Biologics and Roche Forge Strategic Alliance to Advance DLL3-Targeted ADC for Small Cell Lung Cancer
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
January 02, 2025 | News
Radiopharm and Lantheus Join Forces to Advance Radiopharmaceutical Clinical Development in Australia
RAD to advance the clinical development of Lantheus innovative radiopharmaceuticals in Australia Initial collaboration will focus on a Phase 1 imaging t...
December 31, 2024 | News
Australia’s Telix Submits FDA Application for TLX250-CDx, a Breakthrough PET Imaging Agent for Kidney Cancer
Telix Pharmaceuticals Limited announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administrat...
December 30, 2024 | News
Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
In an exclusive interview with BioPharma APAC, Ed Deng, Co-founder and CEO of Health2Sync, delves into the transformative impact of their collabora...
December 24, 2024 | Interaction
CStone Pharmaceuticals Submits Clinical Trial Application in Australia for CS2009, a Tri-Specific Antibody Targeting Solid Tumors
CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therap...
December 23, 2024 | News
Certa Therapeutics Strengthens Asia-Pacific Leadership with Acquisition of Melbourne-Based OccuRx to Advance GPR68-Driven Fibrotic Disease Therapies
Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with fibrotic diseases, today announces the acqu...
December 19, 2024 | News
Australia’s Clarity Pharmaceuticals Expands Pipeline with Novel FAP-Targeted Radiopharmaceutical
Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of...
December 19, 2024 | News
Australia’s Cartherics Secures $300K G-Rex Grant to Advance Manufacturing of Allo CAR-iNK Cells for Ovarian Cancer Trials
- Cartherics has received a US$300K G-Rex grant to support its ‘in house’ manufacturing program- Funding will enable Cartherics to generate cru...
December 18, 2024 | News
SK bioscience to Launch Phase 1/2 Trials for First mRNA Vaccine Candidate in Australia
SK bioscience’s first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2...
December 13, 2024 | News
Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
The Southern Hemisphere’s only mRNA manufacturing facility has officially opened in Victoria, marking a significant milestone for Australia’s h...
December 11, 2024 | News
Actinogen Expands Alzheimer’s Trial Across Australia and US, Eyes Interim Results in 2025
Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 Appoints US-based Chief Commercial Officer, Andrew Udell X...
December 10, 2024 | News
Skyhawk Therapeutics Gains Australian Approval to Extend SKY-0515 Huntington’s Disease Trial to 12 Weeks
Australian Human Research Ethics Committees approves SKY-0515 treatment for up to 12 weeks in the company's ongoing Phase 1 trial in patients with Hun...
December 10, 2024 | News
ShiraTronics Launches Pivotal RELIEV-CM2 Trial with First Neuromodulation Implants for Chronic Migraine in the U.S. and Australia
First Implants of Innovative Device Completed in the United States and Australia ShiraTronics, a clinical-stage innovator in neuromodulatio...
December 04, 2024 | News
Most Read
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
